Market Overview:
The global cardiac valvulotome market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of heart valve diseases, rising geriatric population, and technological advancements in cardiac valvulotomes. Based on type, the global cardiac valvulotome market is segmented into expandable cardiactal valvulotomes and over-the-wire cardiactal valvulotomes. The expandable cardiactal vavlutome segment is expected to grow at a higher CAGR than the over-the-wire cardiactal vavlutome segment during the forecast period from 2018 to 2030. This can be attributed to the advantages offered by expandable valves such as low profile design, conformability with irregular anatomy, and reduced trauma as compared with over-the wire valves.
Product Definition:
A cardiac valvulotome is a surgical instrument used to cut or excise tissue from the heart valves. It is typically used to remove calcium deposits (calcified nodules) from the valves, which can impair their function.
Expandable Cardiac Valvulotome:
Expandable cardiac valve means a kind of balloon-like structure that is placed in the heart to help regulate and control the flow of blood through valves. It helps in opening and closing certain heart valves which are causing blood clots. The medical device works by expanding and contracting, therefore helping to move blood around easily. This allows better function for the affected part of the heart without any obstruction or interference with normal operation.
Over the Wire Cardiac Valvulotome:
Over the wire cardiac valvulotome is a device that helps in opening and closing of heart valves. It works by pressingurging or extracting blood from one chamber to another through a small channel called as “valve” which is situated between two chambers, typically the left chamber contains deoxygenated blood and right chamber contains oxygenated blood.
Application Insights:
Based on the application, the global market is segmented into hospitals, ambulatory surgical centers and others. The hospital segment dominated the market in 2017 owing to increasing prevalence of cardiac diseases and rising number of surgeries. According to a study published by NCBI in 2018, out of which around 6% patients suffer from some kind of heart valve disorder requiring surgery every year. Moreover, according to WHO around 1-2% people die due to these disorders every year making it one of the leading causes of death globally. Thus increasing number cardiac surgeries are driving demand for cardiovascular devices such as valves resulting in higher revenue generation for this segment over others during forecast years.
The other application segment includes clinics/hospitals.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-developed healthcare infrastructure, high adoption rate of advanced technologies, and favorable reimbursement policies are some factors responsible for its large share. Moreover, increasing demand for minimally invasive surgeries owing to the growing geriatric population is expected to drive growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to improving healthcare facilities and an increase in cardiovascular diseases (CVDs). Furthermore, rising disposable income levels will boost demand for technologically advanced products such as cardiac valvulotome that can be used at home instead of going to hospital outpatient departments thus reducing travel time and cost.
Growth Factors:
- Increasing prevalence of heart valve diseases: The global cardiac valvulotome market is expected to grow at a CAGR of 5.5% during the forecast period due to the increasing prevalence of heart valve diseases. According to the American Heart Association, approximately 5 million Americans are living with heart valve disease and this number is estimated to increase by 25% in 2030. This will create a high demand for cardiac valvulotomes in the coming years.
- Technological advancements: The development of novel technologies such as transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of heart valve diseases and is expected to drive the growth of the cardiac valvulotome market during the forecast period. TAVR procedures are less invasive than traditional open-heart surgeries and are becoming increasingly popular among patients owing to their shorter hospital stay and faster recovery time. This is likely to boost demand for cardiac valvulotomes in coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Cardiac Valvulotome Market Research Report
By Type
Expandable Cardiac Valvulotome, Over the Wire Cardiac Valvulotome
By Application
Hospitals, Ambulatory Surgical Centers, Others
By Companies
B. Braun, LeMaitre Vascular, Andramed, BD, Teleflex
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
145
Number of Tables & Figures
102
Customization Available
Yes, the report can be customized as per your need.
Global Cardiac Valvulotome Market Report Segments:
The global Cardiac Valvulotome market is segmented on the basis of:
Types
Expandable Cardiac Valvulotome, Over the Wire Cardiac Valvulotome
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- B. Braun
- LeMaitre Vascular
- Andramed
- BD
- Teleflex
Highlights of The Cardiac Valvulotome Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Expandable Cardiac Valvulotome
- Over the Wire Cardiac Valvulotome
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cardiac Valvulotome Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A cardiac valvulotome is a medical device that helps doctors treat heart conditions. It is a small, hand-held tool that can be used to open and close the valves in the heart. This helps improve blood flow and reduce symptoms of heart disease.
Some of the key players operating in the cardiac valvulotome market are B. Braun, LeMaitre Vascular, Andramed, BD, Teleflex.
The cardiac valvulotome market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cardiac Valvulotome Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cardiac Valvulotome Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cardiac Valvulotome Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cardiac Valvulotome Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cardiac Valvulotome Market Size & Forecast, 2020-2028
4.5.1 Cardiac Valvulotome Market Size and Y-o-Y Growth
4.5.2 Cardiac Valvulotome Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Expandable Cardiac Valvulotome
5.2.2 Over the Wire Cardiac Valvulotome
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cardiac Valvulotome Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cardiac Valvulotome Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Expandable Cardiac Valvulotome
9.6.2 Over the Wire Cardiac Valvulotome
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Expandable Cardiac Valvulotome
10.6.2 Over the Wire Cardiac Valvulotome
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Expandable Cardiac Valvulotome
11.6.2 Over the Wire Cardiac Valvulotome
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Expandable Cardiac Valvulotome
12.6.2 Over the Wire Cardiac Valvulotome
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Expandable Cardiac Valvulotome
13.6.2 Over the Wire Cardiac Valvulotome
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cardiac Valvulotome Market: Competitive Dashboard
14.2 Global Cardiac Valvulotome Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 B. Braun
14.3.2 LeMaitre Vascular
14.3.3 Andramed
14.3.4 BD
14.3.5 Teleflex
